Opportunity Information: Apply for RFA EB 10 002
Apply for RFA EB 10 002
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Development and Translation of Medical Technologies that Reduce Health Disparities (SBIR R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health 93.307 Minority Health and Health Disparities Research.
- This funding opportunity was created on Mar 19, 2010 and posted on Mar 19, 2010.
- Applicants must submit their applications by Jan 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,450,000.00 to eligible and selected applicants.
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Development and Translation of Medical Technologies that Reduce Health Disparities (SBIR R43/R44) funding opportunity (RFA-EB-10-002) is a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant announcement aimed at helping small businesses create and move forward practical medical technologies that can measurably reduce health disparities. In plain terms, the program is designed to support innovations that improve healthcare access and health outcomes for populations that experience disproportionate burdens of disease, worse outcomes, or barriers to receiving care. The emphasis is not just on inventing something new, but on developing and translating it so it can realistically be used in settings where disparity populations receive care.
A central theme of the opportunity is that proposed technologies must be appropriate for real-world use in underserved or disparity-affected communities. NIH highlights several qualities it expects in responsive technologies: they should be effective (meaning they improve care or outcomes in a meaningful way), affordable (so cost does not block adoption), culturally acceptable (so the tool fits the beliefs, language, and lived realities of the people it is meant to serve), and deliverable to those who need them (so the technology can actually reach and function in the intended environments, including clinics and community settings with limited resources). This framing strongly signals that applicants should think beyond technical performance and address practical constraints like usability, workflow fit, training needs, maintenance, and the financial and logistical realities of deployment.
Another defining requirement is formal collaboration. To be considered responsive, an application must involve a formal partnership with a healthcare provider or another healthcare organization that serves a health disparity population. This requirement pushes applicants to build projects with direct input and participation from organizations on the front lines, rather than designing in isolation. Practically, this means the small business should be prepared to document a real, structured collaboration (for example, through letters of support and well-defined roles) and to show how the partner organization will contribute to development, testing, evaluation, and eventual implementation in the target population.
The funding uses the SBIR grant mechanisms R43 and R44, supporting Phase I, Phase II, and Fast Track submissions. Phase I generally supports early feasibility and proof-of-concept work, Phase II supports further development and validation toward commercialization and broader adoption, and Fast Track is intended to accelerate the transition from Phase I to Phase II through a combined application. By offering these tracks, the FOA supports both early-stage innovation and later-stage translation steps that move a technology closer to widespread use, which aligns with the program goal of producing tools that actually reach communities and reduce disparities rather than remaining prototypes.
From an administrative and funding standpoint, this is a discretionary grant opportunity categorized under health-related funding activities and tied to CFDA numbers 93.242 (Mental Health Research Grants), 93.286 (Discovery and Applied Research for Technological Innovations to Improve Human Health), and 93.307 (Minority Health and Health Disparities Research). There is no cost-sharing or matching requirement, which can make participation more feasible for small businesses that may not have large reserves of capital. Eligibility is limited to small businesses, consistent with SBIR rules.
The FOA projected a total of $3,450,000 in FY 2011 funding to support an estimated 7 to 12 awards, with future funding dependent on annual appropriations. The announcement was posted and created on March 19, 2010, with an original and current closing date of January 7, 2011, and an archive date of February 7, 2011. While the archived status indicates the specific submission window has passed, the summary still captures the structure and expectations NIH set for SBIR proposals focused on disparity-reducing medical technologies.
For applicants seeking more details, the announcement provided an additional information link through the NIH grants guide (http://grants.nih.gov/grants/guide/rfa-files/RFA-EB-10-002.html) and directed technical access questions to the NIH Office of Extramural Research (OER) webmaster contact.
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled "The Development and Translation of Medical Technologies that Reduce Health Disparities (SBIR R43/R44)" and is identified as RFA-EB-10-002.
Who is offering this grant opportunity?
This is a National Institutes of Health (NIH) funding opportunity under the Small Business Innovation Research (SBIR) program.
What is the main goal of the program?
The goal is to help small businesses develop and translate practical medical technologies that can measurably reduce health disparities, with an emphasis on solutions that can realistically be used in settings where disparity populations receive care.
What does NIH mean by "reduce health disparities" in this context?
In this opportunity, the focus is on improving healthcare access and health outcomes for populations that experience disproportionate burdens of disease, worse outcomes, or barriers to receiving care.
Is the program focused on inventing new technologies or translating them into real-world use?
NIH emphasizes not only invention, but also development and translation so the technology can be realistically implemented in real-world settings that serve health disparity populations.
What kinds of technology characteristics does NIH expect for a responsive proposal?
NIH highlights that technologies should be effective, affordable, culturally acceptable, and deliverable to the people who need them, including in clinics and community settings with limited resources.
What does "effective" mean for this opportunity?
Effective means the technology improves care or outcomes in a meaningful way, not just that it works technically.
Why is affordability emphasized?
Affordability is emphasized so that cost does not become a barrier to adoption in underserved settings or among disparity-affected populations.
What does "culturally acceptable" mean in the FOA summary?
Culturally acceptable means the technology should fit the beliefs, language, and lived realities of the people it is intended to serve.
What does "deliverable" mean for the proposed technology?
Deliverable means the technology can actually reach the intended users and function in the target environments, including low-resource clinical and community settings.
Does the opportunity expect applicants to address real-world deployment constraints?
Yes. The summary signals applicants should consider practical constraints beyond technical performance, such as usability, workflow fit, training needs, maintenance, and financial and logistical realities of deployment.
Is collaboration required to be considered responsive?
Yes. To be considered responsive, the application must involve a formal partnership with a healthcare provider or another healthcare organization that serves a health disparity population.
What type of partner organization is required?
The partner must be a healthcare provider or another healthcare organization that serves a health disparity population.
What does NIH mean by a "formal partnership"?
The summary indicates the collaboration should be real and structured, supported by documentation such as letters of support and clearly defined roles for the small business and the partner organization.
How is the partner expected to contribute to the project?
The partner organization is expected to contribute to development, testing, evaluation, and eventual implementation in the target population.
What grant mechanisms are used for this opportunity?
The opportunity uses SBIR mechanisms R43 and R44.
What submission tracks are supported under R43/R44?
The FOA supports Phase I, Phase II, and Fast Track submissions.
What is Phase I intended to support?
Phase I generally supports early feasibility and proof-of-concept work.
What is Phase II intended to support?
Phase II supports further development and validation toward commercialization and broader adoption.
What is the Fast Track option?
Fast Track is intended to accelerate the transition from Phase I to Phase II through a combined application.
What is the broader intent behind offering Phase I, Phase II, and Fast Track?
The structure supports both early-stage innovation and later-stage translation steps so technologies move closer to widespread use and do not remain as prototypes.
Who is eligible to apply?
Eligibility is limited to small businesses, consistent with SBIR rules.
Is cost sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement.
What type of grant is this considered administratively?
It is described as a discretionary grant opportunity categorized under health-related funding activities.
Which CFDA numbers are associated with this opportunity?
The summary ties the opportunity to CFDA 93.242 (Mental Health Research Grants), 93.286 (Discovery and Applied Research for Technological Innovations to Improve Human Health), and 93.307 (Minority Health and Health Disparities Research).
How much funding was projected and how many awards were expected?
The FOA projected a total of $3,450,000 in FY 2011 funding to support an estimated 7 to 12 awards, with future funding dependent on annual appropriations.
When was the announcement posted?
The announcement was posted and created on March 19, 2010.
What were the closing date and archive date?
The original and current closing date was January 7, 2011, and the archive date was February 7, 2011.
Is this opportunity still open for applications?
The summary indicates it is archived and that the specific submission window has passed.
Where can applicants find the official FOA details?
The announcement provided an NIH Grants Guide link: http://grants.nih.gov/grants/guide/rfa-files/RFA-EB-10-002.html
Who was listed for technical access questions?
For technical access questions, the announcement directed people to contact the NIH Office of Extramural Research (OER) webmaster contact.
Browse more opportunities from the same category: Health
Next opportunity: Western Pond Turtles Study on the Trinity River
Previous opportunity: NINDS Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA EB 10 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA EB 10 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCMHD Building Research Infrastructure and Capacity (P20) Apply for RFA MD 10 002 Funding Number: RFA MD 10 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Rural Assistance Center for ORHP Cooperative Agreement Apply for HRSA 10 052 Funding Number: HRSA 10 052 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Grants for Alzheimers Disease Drug Discovery (R21) Apply for PAS 10 151 Funding Number: PAS 10 151 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| National HIV Program Apply for HHS 2010 IHS OCPS HIV 0001 Funding Number: HHS 2010 IHS OCPS HIV 0001 Agency: Indian Health Service Category: Health Funding Amount: $90,000 |
| FY10 FP Clinical Training FOA Apply for PA FPT 10 001 Funding Number: PA FPT 10 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $700,000 |
| Geriatric Training Program for Physicians, Dentists, And Behavioral And Mental Health Professions Apply for HRSA 10 044 Funding Number: HRSA 10 044 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Combination HIV Prevention for the General Population of Adults and Youth, including Persons Living with HIV (PLH), in Mozambique Apply for RFA 656 10 005 Funding Number: RFA 656 10 005 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $26,000,000 |
| Puerto Rican Cultural Center, Vida/SIDA Program, Apply for CDC RFA PS10 10177E Funding Number: CDC RFA PS10 10177E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| National Environmental Public Health Tracking Program National Association for Public Health Statistics and Information Systems Apply for CDC RFA EH10 1004 Funding Number: CDC RFA EH10 1004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $125,000 |
| NIBIB Biomedical Technology Resource Centers (P41) Apply for PAR 10 153 Funding Number: PAR 10 153 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Population based surveillance for Deep Vein Thrombosis and Pulmonary Embolism Apply for CDC RFA DD10 1016 Funding Number: CDC RFA DD10 1016 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Geriatric Education Centers Apply for HRSA 10 091 Funding Number: HRSA 10 091 Agency: Health Resources and Services Administration Category: Health Funding Amount: $400,000 |
| Improving Implementation of Programs for Care Treatment of HIV/AIDS in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1081 Funding Number: CDC RFA PS10 1081 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Programs for Pool and Spa Safety Apply for CDC RFA CE10 1002 Funding Number: CDC RFA CE10 1002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Research Opportunities on Spasmodic Dysphonia (R21) Apply for PA 10 156 Funding Number: PA 10 156 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Research Opportunities on Spasmodic Dysphonia (R01) Apply for PA 10 157 Funding Number: PA 10 157 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Career Enhancement Award for Established Investigators (K18) Apply for PAR 10 162 Funding Number: PAR 10 162 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Adolescent Health Earmarks 2010 Apply for CDC RFA DP10 1021E Funding Number: CDC RFA DP10 1021E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19) Apply for PAR 10 161 Funding Number: PAR 10 161 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Research Scientist Development Award (K01) Apply for PAR 10 132 Funding Number: PAR 10 132 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA EB 10 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.